Related Experiment Video
Updated: Mar 13, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis
Abstract:
Although necrosis and necroinflammation are central features of many liver diseases, the role of programmed necrosis in the context of inflammation-dependent hepatocellular death remains to be fully determined. Here, we have demonstrated that the pseudokinase mixed lineage kinase domain-like protein (MLKL), which plays a key role in the execution of receptor-interacting protein (RIP) kinase-dependent necroptosis, is upregulated and activated in human autoimmune hepatitis and in a murine model of inflammation-dependent hepatitis. Using genetic and pharmacologic approaches, we determined that hepatocellular necrosis in experimental hepatitis is driven by an MLKL-dependent pathway that occurs independently of RIPK3. Moreover, we have provided evidence that the cytotoxic activity of the proinflammatory cytokine IFN-γ in hepatic inflammation is strongly connected to induction of MLKL expression via activation of the transcription factor STAT1. In summary, our results reveal a pathway for MLKL-dependent programmed necrosis that is executed in the absence of RIPK3 and potentially drives the pathogenesis of severe liver diseases.
Insights
Programmed necrosis in liver disease involves MLKL activation. This study reveals an MLKL-dependent pathway for hepatocellular death independent of RIPK3, crucial for autoimmune hepatitis.
Area of Science:
- Hepatology
- Immunology
- Cellular Biology
Background:
- Necrosis and necroinflammation are key in liver diseases.
- The role of programmed necrosis in inflammation-driven liver cell death needs clarification.
Purpose of the Study:
- To investigate the role of mixed lineage kinase domain-like protein (MLKL) in inflammation-dependent hepatocellular death.
- To determine the mechanism of MLKL-driven necrosis in experimental hepatitis, particularly its independence from RIPK3.
Main Methods:
- Analysis of MLKL expression and activation in human autoimmune hepatitis and a murine hepatitis model.
- Genetic and pharmacologic approaches to investigate MLKL-dependent necrosis.
- Exploration of the role of interferon-gamma (IFN-γ) and STAT1 in MLKL induction.
Main Results:
- MLKL is upregulated and activated in human and murine hepatitis.
- Hepatocellular necrosis in experimental hepatitis is driven by an MLKL-dependent pathway independent of RIPK3.
- IFN-γ induces MLKL expression via STAT1 activation, linking it to hepatic inflammation.
Conclusions:
- A novel pathway for MLKL-dependent programmed necrosis, independent of RIPK3, has been identified.
- This pathway may contribute to the pathogenesis of severe liver diseases like autoimmune hepatitis.
- Targeting this pathway could offer new therapeutic strategies for liver inflammation.
More Related Videos
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
08:15Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...